Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression
-
By
-
Yanxiao Sun
-
Longtao Zhang
-
Dong Guo
-
June 5, 2026
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
The University of Texas MD Anderson Cancer Center
Houston, Texas
-
#2
Memorial Sloan Kettering Cancer Center
New York, New York
-
#3
Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center
Boston, Massachusetts
-
#4
Harvard Medical School
Boston, Massachusetts
-
#5
Barts Cancer Institute, Queen Mary University of London
London, England
